{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T15:00:09Z","timestamp":1764687609950},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.ygyno.2013.01.012","type":"journal-article","created":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T02:32:49Z","timestamp":1359599569000},"page":"69-73","source":"Crossref","is-referenced-by-count":29,"title":["Does neoadjuvant chemotherapy decrease the risk of hospital readmission following debulking surgery?"],"prefix":"10.1016","volume":"129","author":[{"suffix":"Jr.","given":"Michael J.","family":"Worley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie H.","family":"Guseh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Alejandro","family":"Rauh-Hain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina A.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Muto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colleen M.","family":"Feltmate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross S.","family":"Berkowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil S.","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2013.01.012_bb0005","series-title":"Cancer Facts and Figures 2012","author":"American Cancer Society","year":"2012"},{"key":"10.1016\/j.ygyno.2013.01.012_bb0010","first-page":"524","article-title":"Ovarian cancer: survival and treatment differences by age","volume":"71","author":"Gloeckler","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2013.01.012_bb0015","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ygyno.2008.10.015","article-title":"Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed M\u00fcllerian tumors","volume":"112","author":"Matulonis","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.01.012_bb0020","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ygyno.2005.04.037","article-title":"Treatment patterns by decade of life in elderly women (> or =70years of age) with ovarian cancer","volume":"98","author":"Uyar","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.01.012_bb0025","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/cncr.2820710206","article-title":"Ovarian cancer. Survival and treatment differences by age","volume":"71","author":"Ries","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2013.01.012_bb0030","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/1097-0142(19940115)73:2<377::AID-CNCR2820730223>3.0.CO;2-#","article-title":"National survey of ovarian carcinoma. IV: patterns of care and related survival for older patients","volume":"73","author":"Hightower","year":"1994","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.ygyno.2013.01.012_bb0035","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/sj.bjc.6604298","article-title":"Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival","volume":"98","author":"Wright","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2013.01.012_bb0040","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ygyno.2004.04.022","article-title":"Effectiveness of platinum-based chemotherapy among elderly patients with advanced ovarian cancer","volume":"94","author":"Hershman","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"27","key":"10.1016\/j.ygyno.2013.01.012_bb0045","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJM199912303412706","article-title":"Underrepresentation of patients 65years of age or older in cancer-treatment trials","volume":"341","author":"Hutchins","year":"1999","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ygyno.2013.01.012_bb0050","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ygyno.2004.05.033","article-title":"An assessment of age and other factors influencing protocol versus alternative treatments for patients with epithelial ovarian cancer referred to member institutions: a Gynecologic Oncology Group study","volume":"94","author":"Moore","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.01.012_bb0055","first-page":"1118","article-title":"What is the role of neoadjuvant chemotherapy in the management of ovarian cancer?","volume":"22","author":"Schwartz","year":"2008","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.ygyno.2013.01.012_bb0060","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11912-009-0062-y","article-title":"Contemporary considerations for neoadjuvant chemotherapy in primary ovarian cancer","volume":"11","author":"Schwartz","year":"2009","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.ygyno.2013.01.012_bb0065","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in Stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2013.01.012_bb0070","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1245\/s10434-009-0558-6","article-title":"Does neoadjuvant chemotherapy increase optimal cytoreduction rate in advanced ovarian cancer? Meta-analysis of 21 studies","volume":"16","author":"Kang","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ygyno.2013.01.012_bb0075","article-title":"Neoadjuvant chemotherapy (NACT) is an effective way of managing elderly women with advanced stage ovarian cancer (FIGO Stage IIIC and IV)","author":"Glasgow","year":"2012","journal-title":"J Surg Oncol"},{"issue":"6","key":"10.1016\/j.ygyno.2013.01.012_bb0080","doi-asserted-by":"crossref","first-page":"676.e1","DOI":"10.1016\/j.ajog.2007.10.495","article-title":"Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer","volume":"197","author":"Aletti","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.01.012_bb0085","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ygyno.2011.06.031","article-title":"Morbidity, mortality and overall survival in elderly women undergoing primary surgical debulking for ovarian cancer: a delicate balance requiring individualization","volume":"123","author":"Langstraat","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ygyno.2013.01.012_bb0090","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.ajog.2004.01.078","article-title":"Morbidity of cytoreductive surgery in the elderly","volume":"190","author":"Wright","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ygyno.2013.01.012_bb0095","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.ajog.2005.06.074","article-title":"Safety and efficacy of cytoreductive surgery for epithelial ovarian cancer in elderly and high-risk surgical patients","volume":"193","author":"Sharma","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.01.012_bb0100","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ygyno.2008.03.008","article-title":"Ovarian cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply?","volume":"110","author":"Moore","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.ygyno.2013.01.012_bb0105","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1245\/s10434-009-0558-6","article-title":"Does neoadjuvant chemotherapy increase optimal cytoreduction rate in advanced ovarian cancer? Meta-analysis of 21 studies","volume":"16","author":"Kang","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.ygyno.2013.01.012_bb0110","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"European Organization for Research and Treatment of Cancer-Gynaecological Cancer Group; NCIC Clinical Trials Group. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2013.01.012_bb0115","author":"International Federation of Health Plans"},{"key":"10.1016\/j.ygyno.2013.01.012_bb0120","series-title":"Healthcare reform: pending changes to reimbursement for 30-day readmissions","author":"Foster","year":"2010"},{"key":"10.1016\/j.ygyno.2013.01.012_bb0125","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1056\/NEJMsa0803563","article-title":"Rehospitalizations among patients in the Medicare fee-for-service program","volume":"360","author":"Jencks","year":"2009","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ygyno.2013.01.012_bb0130","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jvs.2012.03.260","article-title":"Developing strategies for predicting and preventing readmissions in vascular surgery","volume":"56","author":"Brooke","year":"2012","journal-title":"J Vasc Surg"},{"issue":"11","key":"10.1016\/j.ygyno.2013.01.012_bb0135","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1701-2163(16)34712-0","article-title":"Ovarian cancer in the elderly patient: are we doing enough?","volume":"32","author":"Renaud","year":"2010","journal-title":"J Obstet Gynaecol Can"},{"issue":"12","key":"10.1016\/j.ygyno.2013.01.012_bb0140","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1007\/s00268-007-9345-3","article-title":"Predictors and outcome of readmission after laparoscopic intestinal surgery","volume":"31","author":"O'Brien","year":"2007","journal-title":"World J Surg"},{"key":"10.1016\/j.ygyno.2013.01.012_bb0145","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.amjsurg.2005.10.038","article-title":"Multivariable analysis of factors associated with hospital readmission after intestinal surgery","volume":"191","author":"Kariv","year":"2006","journal-title":"Am J Surg"},{"issue":"5","key":"10.1016\/j.ygyno.2013.01.012_bb0150","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/IGC.0b013e3182157a19","article-title":"Assessment of risk factors for 30-day hospital readmission after surgical cytoreduction in epithelial ovarian carcinoma","volume":"21","author":"Fauci","year":"2011","journal-title":"Int J Gynecol Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581300022X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581300022X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T22:32:24Z","timestamp":1562625144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082581300022X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S009082581300022X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.01.012","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}